No Influence of APOE Status on Donanemab Efficacy
New data from TRAILBLAZER-ALZ 2 show robust amyloid clearance with donanemab in APOE4 carriers and noncarriers, mitigating the risk of disease progression and dependency.
Source: medscape.com
Page 12 - Mci News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Mci. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Mci Today - Breaking & Trending Today
Mothership's press accreditation suspended for 6 months after second embargo breach in 2 years
Mothership broke an embargo in September about an increase in water prices.
Source: channelnewsasia.com
Novel Tau Blood Biomarker Shows Promise
Plasma MTBR-tau243 reflects changes in tau pathology and can be used to stage AD tauopathy and to determine if cognitive symptoms are likely due to AD pathology.
Source: medscape.com
Promising Phase 2 Results for Novel Oral Alzheimer's Drug
An investigational dual PPAR agonist modifies Alzheimer's pathology and shows cognitive benefit in adults with mild-to-moderate disease and high plasma pTau-217 ratio, early data show.
Source: medscape.com
Is It Time to Scrap Ultraprocessed Foods?
Ultraprocessed foods, which account for about 60% of the American diet, are tied to cancer, diabetes, and heart disease. Now, a growing body of research suggests they also negatively affect the brain.
Source: medscape.com